Subscription
Latest news, explainers and analysis on Subscription. Tracking 6 stories on Arth Vani.
Connected in the graph
Latest on Subscription
IPOBreakingKaramtara Engineering IPO: Issue Oversubscribed 1.84x, Grey Market Premium Steady at ₹75
The initial public offering (IPO) of Karamtara Engineering has been subscribed 1.84 times as of the closing day. The grey market premium (GMP) for the IPO remained stable at ₹75, indicating investor interest.
IPOBreakingShiprocket IPO Opens: Issue Subscribed 62% on Day 1, GMP Suggests 31% Listing Gain
Logistics aggregator Shiprocket's Initial Public Offering (IPO) opened for subscription on August 12, with the issue already subscribed 62% on its first day. The grey market premium (GMP) indicates a potential listing gain of around 31%.
IPOBreakingMilky Mist IPO Fully Subscribed; GMP Hints at ₹162 Listing
The Milky Mist Dairy Food IPO has been fully subscribed on its second day. The grey market premium (GMP) suggests shares could list at ₹162.50, a premium over the IPO price band.
IPOBreakingDhoot Transmission IPO Oversubscribed 8 Times on Day 3
The Initial Public Offering (IPO) of Dhoot Transmission has seen strong demand, being subscribed nearly 8 times by the third day. Grey market indicators suggest a potential listing at a premium on Monday.
IPOBreakingLEAP India IPO: Grey Market Premium Stands at ₹13 on Day 3
The LEAP India IPO is on its third day, with grey market premiums (GMP) indicating a slight positive sentiment. Shares are reportedly trading at a ₹13 premium in the grey market, suggesting investor interest ahead of its listing.
IPOBreakingManipal Health IPO Subscribed 15% on Day 1; Retail Portion at 27%
Manipal Health Enterprises' Initial Public Offering (IPO) saw a slow start on its opening day, with overall subscription reaching just 15%. The retail investor portion was subscribed 27%. The company had previously raised ₹4,167 crore from anchor investors.
Some listings may be sponsored and Arth Vani may earn a referral fee. All information is for educational purposes only — verify terms and suitability with the provider before acting. Not financial advice.